ESSEN Technology

Essen Technology (Beijing) Co., Ltd. is a prominent Chinese medical device company specializing in interventional cardiology products. Founded in 2006, the company is a leader in the development of drug-eluting stents (DES), most notably the BuMA and BuMA Supreme systems. These stents feature a unique 'triple-layer' coating technology designed to optimize drug release and promote rapid endothelialization, thereby reducing the risk of late-stage thrombosis. In 2018, the company was acquired by Terumo Corporation for approximately $130 million, a move that significantly bolstered Terumo's presence in the Chinese cardiovascular market. Essen Technology continues to innovate in the field of coronary interventions, maintaining a strong R&D and manufacturing presence in Beijing.